Figure 1.
Characterization of nanoparticles. (A) Size distribution spectrum of DTIC-NPs – DR5 mAb determined by laser diffraction size detector. (B) Zeta potential of DTIC- NPs-DR5 mAb determined by laser diffraction zeta detector. (C) Image of the NPs dispersed in water or phosphate-buffered solution. (D and E) Morphology of DTIC-NPs and DTIC-NPs – DR5 mAb determined by TEM.
Abbreviations: DTIC, dacarbazine; mAb, monoclonal antibody; NPs, nanoparticles; TEM, transmission electron microscopy.